共 488 条
[1]
Rajkumar SV(2014)International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma Lancet Oncol 15 e538-e548
[2]
Dimopoulos MA(2014)IMWG consensus on risk stratification in multiple myeloma Leukemia 28 269-277
[3]
Palumbo A(2014)Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients Leukemia 28 1122-1128
[4]
Blade J(2008)Improved survival in multiple myeloma and the impact of novel therapies Blood 111 2516-2520
[5]
Merlini G(2003)Review of 1027 patients with newly diagnosed multiple myeloma Mayo Clin Proc 78 21-33
[6]
Mateos MV(2001)Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression Proc Natl Acad Sci U S A 98 11581-11586
[7]
Kumar S(2003)The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma N Engl J Med 349 2483-2494
[8]
Hillengass J(1989)Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease J Clin Oncol 7 1909-1914
[9]
Kastritis E(2011)Biochemical and molecular mechanisms of action of bisphosphonates Bone 49 34-41
[10]
Richardson P(2017)Bisphosphonates in multiple myeloma: an updated network meta-analysis Cochrane Database Syst Rev 12 Cd003188-2208